Showing results (731-740 of 769) with videos related to
Sort By:
Pageof 77
NPJ Vaccines|April 27, 2022
Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamstersGeorge Giorgi Babuadze, Hugues Fausther-Bovendo, Marc-Antoine deLaVega, et al.Molecular Cancer Therapeutics|January 25, 2006
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivoHolly K Koblish, Shuyuan Zhao, Carol F Franks, et al.Annals of Clinical and Translational Neurology|November 6, 2025
Insights Into the Antigenic Repertoire of Unclassified Synaptic AntibodiesMichael Gilligan, John R Mills, Paulina Vargas, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2020
Mathematical Model Impact Analysis of a Real-Life Pre-exposure Prophylaxis and Treatment-As-Prevention Study Among Female Sex Workers in Cotonou, BeninLily Geidelberg, Kate M Mitchell, Michel Alary, et al.The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophreniaC J Schmidt, D S Chapin, J Cianfrogna, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2015
Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaquesLaura Evgin, Sergio A Acuna, Christiano Tanese de Souza, et al.Ebiomedicine|December 3, 2025
Neural synaptic vesicle autoimmunity following aerosolized porcine neural tissue exposure: insights into autoimmune inflammatory polyradiculoneuropathyShannon R Hinson, Pranjal Gupta, Naveen K Paramasivan, et al.Journal of Biomolecular Screening|August 21, 2012
Development and validation of reagents and assays for EZH2 peptide and nucleosome high-throughput screensElsie Diaz, Carl A Machutta, Stephanie Chen, et al.Emerging Microbes & Infections|August 31, 2023
Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigenJoseph Jelinski, Monika M Kowatsch, Marc-Alexandre Lafrance, et al.Nature|October 12, 2012
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsMichael T McCabe, Heidi M Ott, Gopinath Ganji, et al.Pageof 77